Back to Search
Start Over
Visceral leishmaniasis: elimination with existing interventions
- Source :
- The Lancet Infectious Diseases, The Lancet Infectious Diseases; Vol 11
- Publication Year :
- 2011
-
Abstract
- The world's burden of infectious diseases can be substantially reduced by more-effective use of existing interventions. Advances in case detection, diagnosis, and treatment strategies have made it possible to consider the elimination of visceral leishmaniasis in the Indian subcontinent. The priority must now be to effectively implement existing interventions at the community level by actively finding cases in endemic villages and treating them with single-dose liposomal amphotericin B at primary-health-care centres. Once the elimination target of one case per 10,000 population has been reached, combination therapies involving miltefosine and paromomycin can be introduced to ensure long-term availability of several drugs for visceral leishmaniasis and to protect against resistance.
- Subjects :
- medicine.medical_specialty
Paromomycin
Phosphorylcholine
030231 tropical medicine
Population
Psychological intervention
Antiprotozoal Agents
03 medical and health sciences
0302 clinical medicine
Pharmacotherapy
Amphotericin B
medicine
Humans
education
Intensive care medicine
0303 health sciences
education.field_of_study
Miltefosine
030306 microbiology
business.industry
Leishmaniasis
medicine.disease
3. Good health
Infectious Diseases
Visceral leishmaniasis
Immunology
Communicable Disease Control
Leishmaniasis, Visceral
Drug Therapy, Combination
business
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 14733099
- Volume :
- 11
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- The Lancet Infectious Diseases
- Accession number :
- edsair.doi.dedup.....b0481c85acaf545314a0c1148d6b7b9c
- Full Text :
- https://doi.org/10.1016/S1473-3099(10)70320-0